The efficiency frontier approach to economic evaluation of health-care interventions.

BACKGROUND IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. PROPOSED METHODS The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. CONCLUSION This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.

[1]  E. Nord,et al.  QALYs: is the value of treatment proportional to the size of the health gain? , 2010, Health economics.

[2]  R. Topel,et al.  Diminishing Returns?: The Costs and Benefits of Improving Health , 2003 .

[3]  E. Nord,et al.  The value of DALY life: problems with ethics and validity of disability adjusted life years. , 2000, Leprosy review.

[4]  M. Kamlet,et al.  QALYs: some challenges. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[6]  D. Horsky,et al.  Evaluation of Salesforce Size and Productivity Through Efficient Frontier Benchmarking , 1996 .

[7]  Michael Drummond,et al.  Moving the QALY forward: rationale for change. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  Jill Johnes,et al.  Research Funding and Performance in U.K. University Departments of Economics: A Frontier Analysis. , 1995 .

[9]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  Willingness to pay for a QALY , 2003 .

[11]  M Ryan,et al.  Using conjoint analysis to elicit preferences for health care , 2000, BMJ : British Medical Journal.

[12]  W C Black,et al.  The CE Plane , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  A. Bessent,et al.  Efficiency Frontier Determination by Constrained Facet Analysis , 1988, Oper. Res..

[14]  D. Gyrd-Hansen Willingness to pay for a QALY: theoretical and methodological issues. , 2005, PharmacoEconomics.

[15]  M. Weinstein How much are Americans willing to pay for a quality-adjusted life year? , 2008, Medical care.

[16]  M. Drummond,et al.  New Guidelines for Economic Evaluation in Germany and the United Kingdom are We Any Closer to Developing International Standards? , 2008 .

[17]  D Parkin,et al.  The efficiency of the delivery of neonatal care in the UK. , 2001, Journal of public health medicine.

[18]  M Ryan,et al.  Eliciting public preferences for healthcare: a systematic review of techniques. , 2001, Health technology assessment.

[19]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[20]  T. R. Nunamaker,et al.  Using data envelopment analysis to measure the efficiency of non‐profit organizations: A critical evaluation , 1985 .

[21]  A Gafni,et al.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? , 1992, Journal of health economics.

[22]  Uwe Siebert,et al.  When should decision-analytic modeling be used in the economic evaluation of health care? , 2003, The European Journal of Health Economics, formerly: HEPAC.

[23]  M. Mcgregor Cost-utility analysis: use QALYs only with great caution. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  J. L. Pinto,et al.  Incorporating societal concerns for fairness in numerical valuations of health programmes. , 1999, Health economics.

[25]  L. Iezzoni,et al.  Measuring hospital efficiency with frontier cost functions. , 1994, Journal of health economics.

[26]  Benjamin M Craig,et al.  Keep it simple: ranking health states yields values similar to cardinal measurement approaches. , 2009, Journal of clinical epidemiology.

[27]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[28]  B. Helmig,et al.  On the efficiency of public, welfare and private hospitals in Germany over time: a sectoral data envelopment analysis study , 2001, Health services management research.

[29]  Kelvin Lancaster,et al.  Change and Innovation in the Technology of Consumption , 1966 .

[30]  A. Rothberg Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .